1. 首页
  2. 产品目录

3,5-二叔丁基-4-羟基苯甲酸

3,5-Di-tert-butyl-4-hydroxybenzoic Acid （订货以英文为准）

编号：D155029
CAS号：1421-49-4
分子式：C15H22O3
分子量：250.33
货号 品牌 包装 目录价 您的价格 库存 数量 购买
D155029-25g 阿拉丁 25g ¥96.90
请登录
D155029-100g 阿拉丁 100g ¥151.90
请登录
D155029-5g 阿拉丁 5g ¥34.90
请登录
D155029-500g 阿拉丁 500g ¥306.90
请登录
产品名称 3,5-Di-tert-butyl-4-hydroxybenzoic Acid
中文名称 3,5-二叔丁基-4-羟基苯甲酸
CAS号 1421-49-4
分子式（M.F.） C15H22O3
分子量（M.W.） 250.33
溶解性Insoluble in wate, Methanol.
应用3,5-Di-tert-butyl-4-hydroxybenzoic acid was used in the synthesis of antistress agents.
产品介绍3,5-Di-tert-butyl-4-hydroxybenzoic acid is a metabolite of butylated hydroxytoluene.
别名3,5-二(1,1-二甲基乙基)-4-羟基苯甲酸;3,5-二叔丁基对羟基苯甲酸;3,5-二特丁基-4-羟基苯甲酸;4-羟基-3,5-二叔丁基苯甲酸;
Reaxys-RN2651954

技术规格

Background: Progesterone receptors (PRs) are nuclear hormone receptors of the NR3C class, which also includes mineralocorticoid,glucocorticoid and androgen receptors. They exist as homodimers coupled to Hsp90 or HMGB proteins, which are shed upon activation. The major signaling pathway used by progesterone receptors is via direct DNA binding and transcriptional regulation of target genes. They can also signal by binding to other proteins, mainly with transcription factors such as NF-kappaB, AP-1 or STAT. Progesterone receptors are found in the female reproductive tract, mammary glands, brain and pituitary gland and receptor expression is induced by estrogen. Well established functions of progesterone receptors include ovulation, implantation, mammary gland development and maintenance of pregnancy. In addition,progesterone, signaling through the progesterone receptor, increases the ventilatory response of the respiratory centers to carbon dioxide and decreases arterial and alveolar PCO2 in the luteal phase of the menstrual cycle and during pregnancy. The human gene encoding the progesterone receptor has been localized to 11q22.
Applications: WB, IHC, IF
Name of antibody: PGR (Phospho-Ser190)
Immunogen: Synthetic peptide of human PGR (Phospho-Ser190)
Full name: progesterone receptor (Phospho-Ser190)
Synonyms： NR3C3; PGR; PRGR
SwissProt: P06401
IHC positive control: Human breast carcinoma
IHC Recommend dilution: 50-100
WB Predicted band size: 99 kDa
WB Positive control: SKOV3 cells treated with EGF
WB Recommended dilution: 500-1000
IF Positive control: MCF cells
IF Recommended dilution 100-200
搜索质检报告(COA)
搜索MSDS
相关产品